|1.||Berruti, Alfredo: 2 articles (02/2015 - 06/2011)|
|2.||Terzolo, Massimo: 2 articles (02/2015 - 06/2011)|
|3.||Volante, Marco: 1 article (02/2015)|
|4.||Migliore, Cristina: 1 article (02/2015)|
|5.||Papotti, Mauro: 1 article (02/2015)|
|6.||Rapa, Ida: 1 article (02/2015)|
|7.||De Francia, Silvia: 1 article (02/2015)|
|8.||Germano, Antonina: 1 article (02/2015)|
|9.||Odland, Jon Ø: 1 article (07/2012)|
|10.||Channa, Kalavati: 1 article (07/2012)|
08/01/2011 - "There were no non-cancer risks of DDTs and γ-HCHs on adults and children, and there were very low cancer risks of DDD, o,p'-DDE, DDT, α-HCH, β-HCH, γ-HCH based on their total concentrations in all samples. "
06/01/2011 - "Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study."
06/01/2011 - "The study was performed to confirm the correlation of the currently used mitotane (o,p'DDD) threshold of 14 mg/liter with tumor response and to evaluate the additional value of 1,1-(o,p'-dichlorodiphenyl) acetic acid (o,p'DDA) and o,p'DDE (1,1-(o,p'-dichlorodiphenyl)-2,2 dichloroethene) levels for predicting tumor response. "
09/01/2004 - "There were no significant associations between short-to-medium-term serum DDT exposure measures (o'p'-DDE and o'p' and p'p' isomers of DDD and DDT) and malaria years. "
07/01/2012 - "We report on the concentrations of DDT and its metabolites (p,p'- DDE, p,p'-DDT, o,p'-DDE, o,p'-DDD, p,p'-DDD, and o,p'-DDT) in maternal plasma of 255 delivering women residing in three sites along Indian Ocean, namely in malaria endemic where IRS takes place, low risk and non-malaria sites. "
07/01/2012 - "Concentrations of measured compounds were found to be significantly higher in the malaria endemic site (p=0.0001): the geometric mean concentration (95% confidence intervals; n=91) for o,p'-DDE was 9 ng/g lipids (7-10); for p,p'-DDE, 3840 ng/g lipids (3008-4902); for o,p'-DDD, 8 ng/g lipids (6-9); for p,p'-DDD, 26 ng/g lipids (20-32); for o,p'-DDT, 168 ng/g lipids (127-221) and for p,p'-DDT, 2194 ng/g lipids (1706-2823). "
|3.||Breast Neoplasms (Breast Cancer)
03/01/2002 - "Still, we cannot exclude a role for high level exposure to o,p'-DDE, particularly in post-menopausal ER+ breast cancer. "
02/01/2005 - "The finding that the antiestrogens tamoxifen and ICI 182,780, and an environmental estrogen, ortho,para-dichlorodiphenyldichloroethylene (o,p'-DDE), have high binding affinities to the receptor and mimic the actions of E2 has important implications for both the development and treatment of estrogen-dependent breast cancer. "
05/01/2001 - "Some trends from doses of single compounds that are supported by results in the literature were observed for hatchling weight of ethynyl estradiol dosed females, weight gain of indole-3-carbinol dosed males, weight gain and liver somatic index of o,p'-DDE dosed males, spleen somatic index of TCDD dosed males, and weight gain, gonad somatic index and egg gland somatic index of TCDD dosed females. "
|2.||2,2- (2- chlorophenyl- 4'- chlorophenyl)acetic acid
|3.||Acetic Acid (Vinegar)
|6.||Estrogen Receptor Modulators (Antiestrogen)
|10.||Ethinyl Estradiol (Estinyl)